about
Treatment of epilepsy: the GABA-transaminase inhibitor, vigabatrin, induces neuronal plasticity in the mouse retinaVigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptorsEffect of long-term vigabatrin administration on the immature rat brain.Acute encephalopathy associated with vigabatrin in a six-month-old girl.Vigabatrin as a first-choice drug in the treatment of West syndrome.Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: an open study.Pharmacology of vigabatrin.Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy.Drug-induced cerebellar ataxia: a systematic review.Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats.Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy.Treatment of Lennox-Gastaut syndrome: overview and recent findings.Testing antiepileptic drugs in children.Antiepileptic drugs in development: prospects for the near future.Advances in pharmacotherapy: recent developments in the treatment of epilepsy.Investigational antiepileptic drugs for the treatment of childhood seizure disorders: a review of efficacy and safety.Vigabatrin-associated reversible acute psychosis in a child.Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups.Antiepileptic drugs in pediatric practice.Overview of the safety of newer antiepileptic drugs.Vigabatrin as first line therapy in infantile spasms: review of seven patients.Optimizing the indication of vigabatrin in children with refractory epilepsy.Preliminary observations on topiramate in pediatric epilepsies.New antiepileptic drugs: lacosamide, rufinamide, and vigabatrin.Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.Long-term evaluation of vigabatrin (gamma vinyl GABA) in epilepsy.How we treat Bowen's disease with topical photodynamic therapy in Dundee.Is the adenosine receptor modulation of histamine-induced accumulation of inositol phosphates in cerebral cortical slices mediated by effects on calcium ion fluxes?Reduction of plasma alanine aminotransferase during vigabatrin treatment.Antiepileptic drugs, learning, and behavior in childhood epilepsy.Aluminium-Activated Malate Transporters Can Facilitate GABA Transport.Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children.
P2860
Q24617195-24A85E86-7EB2-4EE2-AF7D-FFAD72E54817Q28483144-BE3035FA-9367-4355-9632-54B6E658D8FAQ30597042-3A5FFD4A-BF92-4144-AD02-4D9F967C397CQ31366581-F5A75F71-3B6C-4FC2-AA86-D2E14B555D06Q33886904-52709B11-ACFF-4A9F-8DF7-8B041FF36DA0Q34059617-167EAEF3-EF47-4838-BD46-ECAC72592536Q36223272-20BE773E-08EA-4E78-87D5-CE0F9D8BF991Q36735101-CB7E0EA7-72C9-446B-952D-9B3B82130B1EQ38267726-CE3ACEED-8A4F-4F42-B416-9C086FFB6ECFQ38978862-832DCABC-1C96-41BD-81D7-045A80287A23Q39477425-A890C2AA-AE80-42D0-92C7-E11DACADEE33Q39990727-46C36489-E504-4FDC-9325-333BA3ADECFFQ40570299-FBF2AE51-9700-435F-9501-28A5D7302275Q40748925-4F7E8356-9E81-4EC2-888E-73C656586532Q40774655-A0C9EFE5-6C58-4C4C-9A4F-0C385F9CF5B9Q40798471-97B1E936-5B2E-4B57-AA31-D38643BDAB8FQ40952932-8330C36A-484C-4954-B5E9-9CA976512A8FQ41016769-17E04759-EF15-486F-928D-19D31D1F991AQ41093016-15A18E70-0785-4F01-AB0A-36FADF3A358EQ41418008-C1489EEF-C01B-4543-9226-036C85960A00Q41466029-E9D8C32A-677E-4723-AD04-B969056FDF9AQ41514405-3600BAC7-6433-479E-83F7-660BEBD16807Q42652858-B4A85094-ECB6-41D1-83E2-FA266B506063Q42907006-32DAD200-41A2-4381-9E62-5D7562A76E28Q44430244-B631E1D5-AEA8-4D9D-97F6-60FFFFB780CBQ45103257-22D54D22-A4DC-4D38-AB0E-8BE5E58B169FQ46008893-92834FD6-4671-4483-9649-A367628E6A24Q48891782-B1832453-64A6-4EEA-8CB4-0D816B342309Q51586661-70252A47-A2CF-488A-9541-5AB08C724406Q52184568-2B3B527A-13B2-47F1-ABAD-7CCCD6937582Q52331838-FB6D5C70-6BE5-4BBE-ABA6-B11BBFDC030EQ54263462-0F022D0B-1659-4CB4-B939-E79AB9E06D01
P2860
description
1989 nî lūn-bûn
@nan
1989 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Vigabatrin in the treatment of epilepsy in children
@ast
Vigabatrin in the treatment of epilepsy in children
@en
Vigabatrin in the treatment of epilepsy in children
@nl
type
label
Vigabatrin in the treatment of epilepsy in children
@ast
Vigabatrin in the treatment of epilepsy in children
@en
Vigabatrin in the treatment of epilepsy in children
@nl
prefLabel
Vigabatrin in the treatment of epilepsy in children
@ast
Vigabatrin in the treatment of epilepsy in children
@en
Vigabatrin in the treatment of epilepsy in children
@nl
P2093
P2860
P1476
Vigabatrin in the treatment of epilepsy in children
@en
P2093
Arzimanoglou A
Beaumont D
Livingston JH
P2860
P304
P356
10.1111/J.1365-2125.1989.TB03470.X
P407
P478
27 Suppl 1
P577
1989-01-01T00:00:00Z